| Literature DB >> 30693857 |
Letizia Cattaneo1, Tommaso Manciulli2,1, Carmen-Michaela Cretu3, Maria Teresa Giordani4, Andrea Angheben5, Alessandro Bartoloni6, Lorenzo Zammarchi6, Filippo Bartalesi6, Joachim Richter7, Peter Chiodini8, Gauri Godbole8, Thomas Junghanss9, Marija Stojkovic9, Luigi Sammarchi10, Roberto Dore11, Alessandro Vercelli11, Francesco Benazzo12,1, Fabrizio Cuzzocrea12, Francesca Tamarozzi5, Enrico Brunetti13,1.
Abstract
Cystic echinococcosis (CE) is a zoonosis caused by the larval stage of the tapeworm Echinococcus granulosus. In humans, the infection induces the formation of parasitic cysts mostly in the liver and lungs, but virtually any organ can be affected. CE of the bone is one of the rarest forms of the disease, yet it is also extremely debilitating for patients and hard to manage for clinicians. Unlike abdominal CE, there is currently no expert consensus on the management of bone CE. In this study, we conducted a survey of the clinical records of seven European referral centers for the management of patients with CE and retrieved data on the clinical management of 32 patients with a diagnosis of bone CE. Our survey confirmed that the patients endured chronic debilitating disease with a high rate of complications (84%). We also found that diagnostic approaches were highly heterogeneous. Surgery was extensively used to treat these patients, as well as albendazole, occasionally combined with praziquantel or nitaxozanide. Treatment was curative only for two patients, with one requiring amputation of the involved bone. Our survey highlights the need to conduct systematic studies on bone CE, both retrospectively and prospectively.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30693857 PMCID: PMC6402919 DOI: 10.4269/ajtmh.18-0758
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345